Press Releases

June 28 , 2011
Intarcia Presents Positive Phase 2 48-week Results from ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions

September 22, 2010
Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD

September 16, 2010
Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals